An enzyme-linked immunosorbent assay
to screen for inhibitors of the oncogenic anaplastic lymphoma kinase

 

[<<Previous]

[ <<To the list of latest publications ]

[ Next>> ]

Haematologica 2005. 90: 988-990.
 


Gunby, R. H., Tartari, C. J., Porchia, F., Donella-Deana, A., Scapozza, L., and Gambacorti-Passerini, C.
 

The discovery of novel anti-cancer drugs targeting anaplastic lymphoma kinase (ALK), an oncogenic tyrosine kinase, raises the need for in vitro assays suitable for screening compounds for ALK inhibition. To this aim we have developed and optimized an ALK-specific enzyme-linked immunosorbent assay that employs a novel ALK peptide substrate and purified ALK kinase domain.

Key words: ALCL, ALK, kinase assay, inhibitor screening

Pdf (112 KB) available for downloading at: http://www.haematologica.org >>
 

[<<Previous]

[ <<To the list of latest publications ]

[ Next>> ]